Galderma Group AG is a leading global pure-play dermatology company dedicated exclusively to skin health. Founded in 1981 and headquartered in Zug, Switzerland, the company offers a science-driven por... Galderma Group AG is a leading global pure-play dermatology company dedicated exclusively to skin health. Founded in 1981 and headquartered in Zug, Switzerland, the company offers a science-driven portfolio spanning injectable aesthetics, dermatological skincare, and therapeutic dermatology. It manages a diverse range of internationally recognized brands, including Dysport/Azzalure, Alluzience, Restylane, and Sculptra in aesthetics, as well as Cetaphil and Alastin in skincare. Galderma also provides prescription treatments for conditions such as acne, rosacea, psoriasis, and atopic dermatitis through products like Differin, Epiduo, Soolantra, and Aklief. With operations in over 100 countries, partnerships with healthcare professionals, and a commitment to innovation, Galderma plays a significant role in advancing dermatological science and meeting the needs of patients and consumers worldwide.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Galderma Group is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Galderma Group is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Galderma Group's data?

Start your 30-day free trial to request a data review for Galderma Group.

Start Free Trial

Legal Center Contact Us